This invention discloses an
exosome characteristic
protein composition for diagnosing HIV-related
asymptomatic neurocognitive impairment (ANI), comprising the following characteristic proteins: DSCAM, IGF1, CAMK2D, UPF1, ALDH2, and EIF5A. Compared with non-ANI individuals, the relative abundance of DSCAM and IGF1 is increased in ANI individuals, while the relative abundance of CAMK2D, UPF1, ALDH2, and EIF5A is decreased. This
exosome characteristic
protein composition has the following advantages: (1) high
diagnostic accuracy, comprehensively covering the core pathways of ANI
pathological mechanisms, and accurately identifying ANI patients; (2) high specificity, clearly reflecting the specific expression patterns of
exosome proteins in ANI patients, thereby effectively distinguishing ANI from NCI and
healthy individuals; (3) non-invasive and convenient, based on
peripheral plasma testing, improving subject compliance, and suitable for large-scale screening and long-term follow-up; (4) easy clinical translation: the kits prepared for the above exosome characteristic proteins are easy to operate, can be
mass-produced and used, and can be implemented in hospitals and
disease control centers at all levels, making them suitable for widespread application.